Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LevoCept Phase 3 Contraceptive Efficacy Study
NCT04457076Phase 3Not yet recruiting
- Sponsor
- Sebela Pharmaceuticals
- Start
- Jun 2026
- Primary completion
- Jun 2030
- Modality
- Device-based Delivery
- Countries
- 1
01
Overview
A Phase 3 trial of LevoCept in contraception, sponsored by Sebela Pharmaceuticals. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
LevoCept
03
Conditions
contraception
Beyond the preview
Go deeper on NCT04457076.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04457076.